Page last updated: 2024-10-28

miltefosine and Nasal Diseases

miltefosine has been researched along with Nasal Diseases in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research Excerpts

ExcerptRelevanceReference
"Mucocutaneous leishmaniasis is a serious preventable complication of cutaneous leishmaniasis."1.35[Mucosal complication of cutaneous leishmaniasis]. ( Figueroa, RA; Miranda, MC; Prager, M; Zea, DF, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Calvopina, M1
Jijon, S1
Serrano, E1
Kato, H1
Zea, DF1
Prager, M1
Figueroa, RA1
Miranda, MC1

Other Studies

2 other studies available for miltefosine and Nasal Diseases

ArticleYear
Case Report: Successful Treatment with Miltefosine of Severe New World Mucosal Leishmaniasis Caused by
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:2

    Topics: Aged, 80 and over; Antiprotozoal Agents; Cytochromes b; Dysphonia; Humans; Leishmania guyanensis; Le

2020
[Mucosal complication of cutaneous leishmaniasis].
    Biomedica : revista del Instituto Nacional de Salud, 2009, Volume: 29, Issue:1

    Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney

2009